Clinical Significance of Stress Hyperglycemic Ratio and Glycemic Gap in Ischemic Stroke Patients Treated with Intravenous Thrombolysis

Objective The clinical significance of different glycemic parameters has been rarely investigated in ischemic stroke patients treated with intravenous tissue plasminogen activator (IV tPA). This study was aimed to investigate the association between different glycemic parameters and favorable functional outcome in patients treated with IV tPA. Methods Patients with ischemic stroke who received IV tPA therapy at our stroke center were retrospectively enrolled. Four glycemic parameters were collected including admission glucose, HbA1c, stress hyperglycemia ratio (SHR) and glycemic gap (GG). Additional information was also recorded including demographics, medical history, stroke severity, imaging measures and mRS score at discharge. We used 5 machine learning models to investigate the predictive value of glycemic parameters. Results Our study included 294 patients treated with IV tPA. SHR and GG were independently associated with favorable functional outcome (adjusted OR for SHR 0.03, 95% CI 0.01–0.72, P = 0.03; adjusted OR for GG 1.024, 95% CI 1.00–1.05, P = 0.04). Conclusion SHR and GG were associated with functional outcomes in acute ischemic stroke patients with intravenous thrombolysis.

[1]  Feng Yan,et al.  Prevalence of stroke in China, 2013–2019: A population-based study , 2022, The Lancet regional health. Western Pacific.

[2]  V. Durkalski,et al.  Intensive Versus Standard Treatment of Hyperglycemia in Acute Ischemic Stroke Patient: A Randomized Clinical Trial Subgroups Analysis , 2022, Stroke.

[3]  Changyi Wang,et al.  Prognostic Significance of Admission Glucose Combined with Hemoglobin A1c in Acute Ischemic Stroke Patients with Reperfusion Therapy , 2022, Brain sciences.

[4]  D. Hughes,et al.  Predicting 90-day modified Rankin Scale score with discharge information in acute ischaemic stroke patients following treatment , 2021, BMJ Neurology Open.

[5]  Ana Catarina Fonseca,et al.  European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke , 2021, European stroke journal.

[6]  A. Gąsecka,et al.  The Importance of Non-Coding RNAs in Neurodegenerative Processes of Diabetes-Related Molecular Pathways , 2020, Journal of clinical medicine.

[7]  M. Slevin,et al.  Monomeric C-Reactive Protein Aggravates Secondary Degeneration after Intracerebral Haemorrhagic Stroke and May Function as a Sensor for Systemic Inflammation , 2020, Journal of clinical medicine.

[8]  C. Khoo,et al.  Stress Hyperglycaemia is Associated with Poor Functional Outcomes in Patients with Acute Ischaemic Stroke after Intravenous Thrombolysis. , 2020, QJM : monthly journal of the Association of Physicians.

[9]  D. Coursin,et al.  Treatment of Hyperglycemia in Patients With Acute Stroke. , 2019, JAMA.

[10]  Correction to: Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. , 2019, Stroke.

[11]  W. Powers,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. , 2019, Stroke.

[12]  Askiel Bruno,et al.  Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial. , 2019, JAMA.

[13]  Thalia Shoshana Field,et al.  Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke , 2018, JAMA.

[14]  Byeong-Chae Kim,et al.  HbA1c (Glycated Hemoglobin) Levels and Clinical Outcome Post-Mechanical Thrombectomy in Patients With Large Vessel Occlusion , 2019, Stroke.

[15]  H-S Chen,et al.  Usefulness of the plasma glucose concentration-to-HbA1c ratio in predicting clinical outcomes during acute illness with extreme hyperglycaemia. , 2017, Diabetes & metabolism.

[16]  Yilong Wang,et al.  Prognosis of Ischemic Stroke With Newly Diagnosed Diabetes Mellitus According to Hemoglobin A1c Criteria in Chinese Population , 2016, Stroke.

[17]  Eric E. Smith,et al.  Association of Acute and Chronic Hyperglycemia With Acute Ischemic Stroke Outcomes Post‐Thrombolysis: Findings From Get With The Guidelines‐Stroke , 2015, Journal of the American Heart Association.

[18]  R. Marshall.  Progress in Intravenous Thrombolytic Therapy for Acute Stroke. , 2015, JAMA neurology.

[19]  Yuhua Fan,et al.  Optimising outcome assessment to improve quality and efficiency of stroke trials , 2014, Expert review of pharmacoeconomics & outcomes research.

[20]  Gary A. Ford,et al.  Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated With Intravenous Alteplase: Safe Implementation of Treatments in Stroke (SITS) Symptomatic Intracerebral Hemorrhage Risk Score , 2012, Stroke.

[21]  L. Kappelle,et al.  Diabetes, hyperglycaemia, and acute ischaemic stroke , 2012, The Lancet Neurology.

[22]  M. Kaste,et al.  Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR). , 2010, Archives of neurology.

[23]  Joanna Wardlaw,et al.  Stroke treatment with alteplase given 3·0–4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial , 2009, The Lancet Neurology.

[24]  E. Kilpatrick,et al.  Translating the A1C Assay Into Estimated Average Glucose Values , 2009, Diabetes Care.

[25]  K. Huybrechts,et al.  The Prognostic Value of the Modified Rankin Scale Score for Long-Term Survival after First-Ever Stroke , 2008, Cerebrovascular Diseases.

[26]  D. Schoenfeld,et al.  Translating the A1C Assay Into Estimated Average Glucose Values , 2008, Diabetes Care.

[27]  Werner Hacke,et al.  Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study , 2007, The Lancet.

[28]  J. Arenillas,et al.  Acute Hyperglycemia State Is Associated With Lower tPA-Induced Recanalization Rates in Stroke Patients , 2005, Stroke.

[29]  M. Itoh,et al.  Participation of high glucose concentrations in neutrophil adhesion and surface expression of adhesion molecules on cultured human endothelial cells: effect of antidiabetic medicines. , 2002, Journal of diabetes and its complications.

[30]  S. Dimmeler,et al.  Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. , 2001, The Journal of clinical investigation.

[31]  H. Gerstein,et al.  Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview , 2001, Stroke.

[32]  G. Pellegrini,et al.  Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat , 2001, Acta Diabetologica.

[33]  N. Vaziri,et al.  Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. , 2000, American journal of physiology. Endocrinology and metabolism.

[34]  D. Singer,et al.  Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. , 2000, JAMA.

[35]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[36]  T. Brott,et al.  Improved Reliability of the NIH Stroke Scale Using Video Training , 1994, Stroke.

[37]  B. Sobel,et al.  Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[38]  R. Busto,et al.  Moderate Hyperglycemia Worsens Acute Blood‐Brain Barrier Injury After Forebrain Ischemia in Rats , 1993, Stroke.

[39]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.